MedTrace Logo

TITAN™ Reverse Shoulder System

NCT02204228 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 151

Last updated 2026-03-13

No results posted yet for this study

Summary

The Integra® TITAN™ Reverse Shoulder System (TRS) is a semi-constrained total shoulder construct. When used under the conditions and purposes intended the TRS will relieve pain and restore some functional joint motion to the affected shoulder. The purpose of this study is to assess the short, mid and long term outcomes of the TITAN™ Reverse Shoulder System.

Conditions

  • Osteoarthritis of the Shoulder

Interventions

DEVICE

TITAN™ Reverse Shoulder System (TRS)

All patients will be operated on with the TITAN™ Reverse Shoulder System (TRS).

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Principal Investigators

  • Karlie Morgan · Smith & Nephew, Inc.

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2023-12-14
Completion
2023-12-14
FDA Device
Yes

Countries

  • United States
  • France
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02204228 on ClinicalTrials.gov